Theme
Biotech '26: Scalable Oncology Drugs☆
ACLX-22.05%8.3%
BBOT-68.13%8.3%
BMY+36.87%8.3%
CMPX-73.70%8.3%
GMAB+10.13%8.3%
JAZZ+72.55%8.3%
KURA+23.41%8.3%
LEGN-40.38%8.3%
NRIX+155.23%8.3%
NUVL0.00%8.3%
RVMD+347.90%8.3%
ZYME+53.85%8.3%
As of Oct 2, 2026, 9:55 PM ET
Biotech '26: Scalable Oncology Drugs Constituents
Arcellx, Inc.ACLX | 8.3% | 0.00% | 0.00% | 0.00% | 0.00% | -1.67% | 0.00% | -4.64% | -22.05% | -15.87% | 281.61% | $3.75B |
BridgeBio Oncology Therapeutics Inc.BBOT | 8.3% | -1.27% | -14.91% | -55.40% | 0.63% | -68.33% | -60.47% | -60.35% | -68.13% | -61.10% | -61.10% | $311.6M |
Bristol-Myers Squibb CompanyBMY | 8.3% | -0.50% | -0.82% | -8.75% | 0.46% | 14.46% | -1.01% | 4.71% | 36.87% | 15.35% | 16.54% | $124.91B |
Compass Therapeutics, Inc.CMPX | 8.3% | -4.93% | -26.40% | -62.44% | 1.28% | -83.01% | -83.85% | -46.00% | -73.70% | -54.91% | -75.59% | $154.3M |
Genmab A/SGMAB | 8.3% | 0.58% | 0.44% | 3.39% | 2.39% | 14.85% | 20.16% | 87.96% | 10.13% | 48.50% | -19.49% | $21.33B |
Jazz Pharmaceuticals plcJAZZ | 8.3% | 1.14% | -1.59% | -3.59% | 1.61% | 39.26% | 24.59% | 87.24% | 72.55% | 117.09% | 81.33% | $14.80B |
Kura Oncology, Inc.KURA | 8.3% | 0.00% | -3.84% | -13.96% | 5.92% | 8.57% | 29.21% | 73.01% | 23.41% | -41.42% | -44.33% | $945.4M |
Legend Biotech CorporationLEGN | 8.3% | -3.88% | 3.27% | -12.06% | -0.36% | -11.45% | 1.32% | -42.09% | -40.38% | -61.14% | -63.02% | $3.43B |
Nurix Therapeutics, Inc.NRIX | 8.3% | -1.50% | -9.72% | -10.24% | -0.71% | 22.17% | 45.12% | 103.65% | 155.23% | 6.09% | -26.41% | $2.39B |
Nuvalent, Inc.NUVL | 8.3% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -8.83% | $1.62B |
Revolution Medicines, Inc.RVMD | 8.3% | 0.36% | 6.13% | -2.17% | -0.58% | 156.99% | 100.64% | 491.59% | 347.90% | 347.95% | 609.62% | $43.93B |
Zymeworks Inc.ZYME | 8.3% | -3.12% | -5.68% | -16.26% | 0.15% | -1.25% | 11.64% | 118.12% | 53.85% | 106.32% | -14.25% | $1.85B |
| Theme return | — | -1.09% | -4.43% | -18.56% | 0.90% | 0.49% | 1.65% | 52.48% | 22.13% | 30.00% | 76.80% | — |
| Average | 8.3% | -1.09% | -4.43% | -15.12% | 0.90% | 7.55% | 7.28% | 67.77% | 41.31% | 33.90% | 56.34% | $18.29B |
| Median | 8.3% | -0.25% | -1.20% | -9.50% | 0.31% | 4.29% | 6.48% | 38.86% | 16.77% | 3.05% | -16.87% | $2.91B |
| Std Dev | 0.0% | 1.84% | 8.55% | 20.49% | 1.75% | 56.42% | 44.92% | 141.27% | 110.69% | 110.82% | 190.72% | $34.44B |
| Min | 8.3% | -4.93% | -26.40% | -62.44% | -0.71% | -83.01% | -83.85% | -60.35% | -73.70% | -61.14% | -75.59% | $154.3M |
| Max | 8.3% | 1.14% | 6.13% | 3.39% | 5.92% | 156.99% | 100.64% | 491.59% | 347.90% | 347.95% | 609.62% | $124.91B |
| % Positive Tickers | 25.00% | 25.00% | 8.33% | 58.33% | 50.00% | 58.33% | 58.33% | 58.33% | 50.00% | 33.33% |
Default: Wgt ↓ · Click headers to sort · Shift+click secondaryWgt ↓ · Scroll right · Tap headers to sort